Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
11 NEW September 18, 2023
CMV breakthrough and resistance to antiviral drug after blood stem cell transplants

CMV breakthrough and resistance to antiviral drug after blood stem cell transplants

From Dr. Danniel Zamora and the Boeckh Group, Vaccine and Infectious Disease Division
Science SpotlightApril 17, 2023
From the freezers, a speedier way to evaluate antiviral drugs

From the freezers, a speedier way to evaluate antiviral drugs

Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Hutch NewsNovember 09, 2020
Scientists learn how common virus reactivates after transplantation

Scientists learn how common virus reactivates after transplantation

New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
News ReleasesJanuary 17, 2019
Rethinking an old viral foe

Rethinking an old viral foe

Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Hutch NewsJanuary 17, 2019
Adam Geballe elected AAAS Fellow

Adam Geballe elected AAAS Fellow

Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts
Hutch NewsNovember 20, 2017
New vaccine may prevent cytomegalovirus infection

New vaccine may prevent cytomegalovirus infection

Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child
Hutch NewsMarch 23, 2009